Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideoOut 100
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2024 Pride Publishing Inc.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Private Policy and Terms of Use.
HIVers who switch from Combivir to Truvada improve their chances of suppressing HIV viral levels to below 50, according to a study presented at the 45th Interscience Conference on Antimicrobial Agents and Chemotherapy. About 59% of the study's 198 subjects had a viral load below 50 prior to switching to Truvada, but that percentage climbed to 76% after changing drugs. A label change for Reyataz says the protease inhibitor should be dosed separately from Videx. Reyataz should be taken with food two hours before or one hour after taking Videx, according to the new instructions. Improvements in blood lipid levels are greater when switching from Retrovir or Zerit to cocktails containing Viread as opposed to switching to Ziagen, according to a study presented at the 45th Interscience Conference on Antimicrobial Agents and Chemotherapy. At the 48-week point after switching, patients changing to Viread posted decreases in total cholesterol and LDL cholesterol levels, compared to slight increases among those switching to Ziagen. A study presented at the 13th Conference on Retroviruses and Opportunistic Infections showed that although some protease inhibitors should not be taken along with acid-reducing medications, it is safe to take the acid-lowering drugs with Kaletra. Serono Laboratories completed a Phase III clinical trial of its recombinant human growth hormone Serostim in treating HIV-related fat redistribution and plans to file for FDA approval of the treatment in the first half of this year. Serostim is currently approved to treat HIV-related wasting. Pregnant HIV-positive women resistant to antiretroviral drugs can still prevent transmitting the virus to their infants by adding Fuzeon to their failing drug regimens, according to two case studies reported in the January 9 edition of the journal AIDS. A 48-week study of drug-resistant HIVers has shown that Aptivus, when boosted with Norvir, achieves a greater decrease in HIV viral levels than four other boosted protease drugs. More than 33% of drug-resistant patients taking Aptivus achieved a significant reduction in viral levels, compared to slightly more than 15% of those taking the other boosted protease inhibitors. Data from a 96-week study comparing Norvir-boosted Reyataz to Kaletra has shown that both drugs achieve a similar level of viral control but that Reyataz decreases total cholesterol and fasting triglyceride levels while Kaletra raises blood-lipid levels. Tibotec has opened an early-access program for its experimental protease inhibitor TMC114. The program is open to 5,000 HIVers who are resistant to other anti-HIV medications. For more information and complete enrollment requirements, send e-mail to info@veritasmedicine.com.
From our Sponsors
Most Popular
Before AIDS, gay artist Rex drew hot men on the prowl — then he disappeared
April 11 2024 3:15 PM
The science behind U=U has been liberating people with HIV for years
June 04 2024 3:31 PM
On Anal Sex Day, crack up with The Bottom's Digest
April 18 2024 10:22 AM
As Pride party season begins, the CDC urges mpox vaccinations
May 16 2024 6:52 PM
Todrick Hall has long supported the communities he comes from
April 17 2024 12:02 PM
The freedom of disclosure: David Anzuelo's journey through HIV, art, and advocacy
August 02 2024 12:21 PM
Exclusive: We kiki with Q from 'RuPaul's Drag Race'
June 24 2024 11:37 AM
Plus: Featured Video
Latest Stories
How fitness coach Tyriek Taylor reclaims his power from HIV with self-commitment
September 19 2024 12:00 PM
Out100 Honoree Tony Valenzuela thanks queer and trans communities for support in his HIV journey
September 18 2024 12:00 PM
Kentucky bans conversion therapy for youth as Gov. Andy Beshear signs 'monumental' order
September 18 2024 11:13 AM
Why activist Raif Derrazi thinks his HIV diagnosis is a gift
September 17 2024 12:00 PM
Creator and host Karl Schmid fights HIV stigma with knowledge
September 12 2024 12:03 PM
Study finds use of puberty blockers safe and reversible, countering anti-trans accusations
September 11 2024 1:11 PM
Latinx health tips / Consejos de salud para latinos (in English & en espanol)
September 10 2024 4:29 PM
The Trevor Project receives $5M grant to support LGBTQ+ youth mental health in rural Midwest (exclusive)
September 03 2024 9:30 AM
Introducing 'Health PLUS Wellness': The Latinx Issue!
August 30 2024 3:06 PM
La ciencia detrás de U=U ha estado liberando a las personas con VIH durante años
August 23 2024 2:48 PM
Tratamiento y prevención del VIH por inyección: Todo lo que necesita saber
August 23 2024 2:41 PM
Sr. Gay World quiere asegurarse de que estés bien
August 23 2024 2:30 PM
Eureka is taking a break from competing on 'Drag Race' following 'CVTW' elimination
August 20 2024 12:21 PM
With a new case in Sweden, what is the new mpox outbreak and should you be concerned?
August 15 2024 4:48 PM
From ‘The Real World’ to real life: How Danny Roberts thrives with HIV
July 31 2024 5:23 PM
The July/Aug 'Treatment Guide' issue of Plus is here!
June 26 2024 3:49 PM
Activist and philanthropist Bruce Bastian dies at 76
June 26 2024 1:28 PM